COVID-19 meta-analyses: a scoping review and quality assessment.
Gabriel Natan PiresAndréia Gomes BezerraThainá Baenninger de OliveiraSamuel Fen I ChenVictor Davis Apostolakis MalfattiVictoria Feiner Ferreira de MelloAlyne NiyamaVitor Luiz Selva PintoMonica Levy AndersenSergio TufikPublished in: Einstein (Sao Paulo, Brazil) (2021)
Although well-designed meta-analyses about COVID-19 disease have already been published, the majority are of low quality. Thus, all stakeholders playing a role in COVID-19 deseases, including policy makers, researchers, publishers and journals, should prioritize well-designed meta-analyses, performed only when the background information seem suitable, and discouraging those of low quality or that use suboptimal methods.